PERK LABS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.015 CAD | 0.00% |
|
0.00% | +50.00% |
| Apr. 25 | Perk Labs Inc. announced that it has received CAD 1.714 million in funding | CI |
| Mar. 26 | Perk Labs Inc. Announces Agreement with Bird Fuels for A Custom Payment Solution | CI |
Valuation
| Fiscal Period: November | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 399.7 | 30.08 | 7.521 | 8.038 | 9.936 | 2.026 |
| Enterprise Value (EV) 1 | 389.4 | 24.46 | 3.009 | 7.111 | 7.165 | 1.757 |
| P/E ratio | -25.4 x | -2.28 x | -0.93 x | -1.74 x | -6.42 x | -0.57 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 373 x | 17.7 x | 234 x | 126 x | 343 x | 64.2 x |
| EV / Revenue | 364 x | 14.4 x | 93.7 x | 111 x | 248 x | 55.6 x |
| EV / EBITDA | -43 x | -1.97 x | -0.42 x | -2.2 x | -2.24 x | -0.69 x |
| EV / FCF | -246 x | -2.65 x | -1.47 x | -4.76 x | -5.32 x | -1.42 x |
| FCF Yield | -0.41% | -37.8% | -68.2% | -21% | -18.8% | -70.6% |
| Price to Book | 34.5 x | 2.52 x | 1.72 x | 7.94 x | 3.68 x | 8.89 x |
| Nbr of stocks (in thousands) | 126,876 | 136,738 | 136,738 | 146,150 | 180,650 | 202,645 |
| Reference price 2 | 3.150 | 0.2200 | 0.0550 | 0.0550 | 0.0550 | 0.0100 |
| Announcement Date | 3/29/18 | 3/21/19 | 3/30/20 | 3/26/21 | 3/2/22 | 2/21/23 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: November | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1.07 | 1.695 | 0.0321 | 0.0639 | 0.0289 | 0.0316 |
| EBITDA 1 | -9.053 | -12.43 | -7.122 | -3.238 | -3.203 | -2.565 |
| EBIT 1 | -9.122 | -12.67 | -7.41 | -3.267 | -3.206 | -2.566 |
| Operating Margin | -852.13% | -747.74% | -23,088.77% | -5,113.38% | -11,075.25% | -8,122.3% |
| Earnings before Tax (EBT) 1 | -9.756 | -13.03 | -8.079 | -4.491 | -1.487 | -3.378 |
| Net income 1 | -9.756 | -13.03 | -8.079 | -4.491 | -1.487 | -3.378 |
| Net margin | -911.37% | -768.72% | -25,173.66% | -7,028.51% | -5,138.05% | -10,695.76% |
| EPS 2 | -0.1238 | -0.0966 | -0.0591 | -0.0317 | -0.008564 | -0.0174 |
| Free Cash Flow 1 | -1.582 | -9.246 | -2.052 | -1.495 | -1.347 | -1.241 |
| FCF margin | -147.77% | -545.46% | -6,394.33% | -2,339.03% | -4,653.98% | -3,928.73% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/29/18 | 3/21/19 | 3/30/20 | 3/26/21 | 3/2/22 | 2/21/23 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: November | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 10.3 | 5.63 | 4.51 | 0.93 | 2.77 | 0.27 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -1.58 | -9.25 | -2.05 | -1.49 | -1.35 | -1.24 |
| ROE (net income / shareholders' equity) | -155% | -111% | -99% | -166% | -78.6% | -229% |
| ROA (Net income/ Total Assets) | -81% | -61.6% | -53.9% | -64.1% | -83.1% | -87.6% |
| Assets 1 | 12.04 | 21.16 | 15 | 7.002 | 1.789 | 3.858 |
| Book Value Per Share 2 | 0.0900 | 0.0900 | 0.0300 | 0.0100 | 0.0100 | 0 |
| Cash Flow per Share 2 | 0.0800 | 0.0400 | 0.0100 | 0.0100 | 0.0100 | 0 |
| Capex 1 | 0.12 | 0.38 | 0.02 | - | 0 | - |
| Capex / Sales | 11% | 22.43% | 51.03% | - | 8.13% | - |
| Announcement Date | 3/29/18 | 3/21/19 | 3/30/20 | 3/26/21 | 3/2/22 | 2/21/23 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +50.00% | 5.49M | |
| +18.66% | 414B | |
| +15.27% | 242B | |
| +12.15% | 144B | |
| +20.63% | 104B | |
| +17.19% | 83.87B | |
| +54.11% | 57.64B | |
| +33.59% | 53.37B | |
| +6.02% | 37.83B | |
| +15.88% | 34.11B |
- Stock Market
- Equities
- PERK Stock
- Financials Perk Labs Inc.
